Optimal Injection Site for Serratus Anterior Plane Block in Reconstructive Breast Surgery
Withdrawn before enrolling · Phase 3
Conditions studied: Pain, Postoperative
In brief
The novel introduction of various chest wall blocks such as the Pecs I and II/modified Pecs blocks as well as the Serratus Anterior Plane Block have extended the application of perioperative regional anesthesia to provide analgesia for breast surgery. However, to our knowledge, there are no large studies that truly delineate the optimal injection site for the Serratus Anterior Plane Block.
Key facts
- Study ID
- NCT03183596
- Run by
- University of Alabama at Birmingham
- People needed
- 0
- Starts
- 2019-12-01
- Expected to finish
- 2024-01-01
- Last updated by the study team
- 2018-05-31
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients undergoing reconstructive breast surgery
You may not qualify if…
- Patients with allergies to the local anesthetic
- Patients who do no consent to regional anesthesia
- Patients in which serratus block would be contraindicated
- Patients whose anatomy preclude placement of the block
Where it is running
- UAB Department of Anesthesiology and Perioperative Medicine — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.